DK2427449T3 - Vinylindazolylforbindelser - Google Patents

Vinylindazolylforbindelser

Info

Publication number
DK2427449T3
DK2427449T3 DK10717402.1T DK10717402T DK2427449T3 DK 2427449 T3 DK2427449 T3 DK 2427449T3 DK 10717402 T DK10717402 T DK 10717402T DK 2427449 T3 DK2427449 T3 DK 2427449T3
Authority
DK
Denmark
Prior art keywords
vinylindazolyl
compounds
vinylindazolyl compounds
Prior art date
Application number
DK10717402.1T
Other languages
English (en)
Inventor
Daohong Chen
Hong-Yu Li
Genshi Zhao
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK2427449T3 publication Critical patent/DK2427449T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
DK10717402.1T 2009-05-07 2010-05-04 Vinylindazolylforbindelser DK2427449T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17629009P 2009-05-07 2009-05-07
US30141610P 2010-02-04 2010-02-04
PCT/US2010/033487 WO2010129509A1 (en) 2009-05-07 2010-05-04 Vinyl indazolyl compounds

Publications (1)

Publication Number Publication Date
DK2427449T3 true DK2427449T3 (da) 2013-04-22

Family

ID=42238704

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10717402.1T DK2427449T3 (da) 2009-05-07 2010-05-04 Vinylindazolylforbindelser

Country Status (35)

Country Link
US (1) US8268869B2 (da)
EP (1) EP2427449B1 (da)
JP (1) JP5555314B2 (da)
KR (1) KR101373910B1 (da)
CN (1) CN102421769B (da)
AR (1) AR078411A1 (da)
AU (1) AU2010246114B2 (da)
BR (1) BRPI1013748A2 (da)
CA (1) CA2760535C (da)
CL (1) CL2011002781A1 (da)
CO (1) CO6450624A2 (da)
CR (1) CR20110580A (da)
DK (1) DK2427449T3 (da)
EA (1) EA018149B1 (da)
EC (1) ECSP11011441A (da)
ES (1) ES2408117T3 (da)
HK (1) HK1163665A1 (da)
HN (1) HN2011002809A (da)
HR (1) HRP20130323T1 (da)
IL (1) IL216004A (da)
JO (1) JO2860B1 (da)
MA (1) MA33244B1 (da)
ME (1) ME01462B (da)
MX (1) MX2011011342A (da)
MY (1) MY160390A (da)
NZ (1) NZ595553A (da)
PE (2) PE20160124A1 (da)
PL (1) PL2427449T3 (da)
PT (1) PT2427449E (da)
RS (1) RS52795B (da)
SG (1) SG175909A1 (da)
SI (1) SI2427449T1 (da)
TW (1) TWI382982B (da)
UA (1) UA104756C2 (da)
WO (1) WO2010129509A1 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3062B1 (ar) * 2010-10-05 2017-03-15 Lilly Co Eli R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
AU2013228389A1 (en) 2012-03-08 2014-09-25 Astellas Pharma Inc. Novel FGFR3 fusion product
IL289834B1 (en) 2012-06-13 2024-03-01 Incyte Holdings Corp Conversion of tricyclic compounds as FGFR inhibitors
US20150203589A1 (en) 2012-07-24 2015-07-23 The Trustees Of Columbia University In The City Of New York Fusion proteins and methods thereof
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
EP2968551B1 (en) 2013-03-15 2021-05-05 The Trustees of Columbia University in the City of New York Fusion proteins and methods thereof
SG10201708520YA (en) 2013-04-19 2017-12-28 Incyte Corp Bicyclic heterocycles as fgfr inhibitors
CN103819396B (zh) * 2014-02-26 2016-06-15 四川大学 一种手性的1-(3,5-二氯吡啶-4-基)-乙醇的合成方法
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
EP3778644A3 (en) 2014-12-23 2021-06-02 The Trustees of Columbia University in the City of New York Fgfr-tacc fusion proteins and methods thereof
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
MX2017010673A (es) 2015-02-20 2018-03-21 Incyte Corp Heterociclos biciclicos como inhibidores de receptores del factor de crecimiento fibroblastico (fgfr).
CN105906621A (zh) * 2015-04-06 2016-08-31 四川百利药业有限责任公司 用作fgfr抑制剂的乙醇类化合物
WO2016187767A1 (en) * 2015-05-25 2016-12-01 Hutchison Medipharma Limited Pharmaceutical compositions and use thereof
US10519133B2 (en) * 2015-08-07 2019-12-31 Medshine Discovery Inc. Vinyl compounds as FGFR and VEGFR inhibitors
EP3339305B1 (en) 2015-08-20 2022-05-04 Zhejiang Hisun Pharmaceutical Co., Ltd Indole derivative, preparation method thereof, and use thereof in pharmaceutical drug
CN107459519A (zh) 2016-06-06 2017-12-12 上海艾力斯医药科技有限公司 稠合嘧啶哌啶环衍生物及其制备方法和应用
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
CR20200590A (es) 2018-05-04 2021-04-26 Incyte Corp Formas sólidas de un inhibidor de fgfr y procesos para prepararlas
US11174257B2 (en) 2018-05-04 2021-11-16 Incyte Corporation Salts of an FGFR inhibitor
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
JP2022552324A (ja) 2019-10-14 2022-12-15 インサイト・コーポレイション Fgfr阻害剤としての二環式複素環
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021088859A1 (zh) * 2019-11-06 2021-05-14 暨南大学 吲唑类化合物及其药用组合物和应用
US11897891B2 (en) 2019-12-04 2024-02-13 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors
BR112022010664A2 (pt) 2019-12-04 2022-08-16 Incyte Corp Derivados de um inibidor de fgfr
WO2021138391A1 (en) * 2019-12-30 2021-07-08 Tyra Biosciences, Inc. Indazole compounds
EP4186894A4 (en) * 2020-08-11 2024-01-17 Henan Medinno Pharmaceutical Tech Co Ltd FGFR INHIBITOR COMPOUND AND ITS USE
US11939331B2 (en) 2021-06-09 2024-03-26 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
EP1317442B1 (en) 2000-09-11 2005-11-16 Chiron Corporation Quinolinone derivatives as tyrosine kinase inhibitors
US7495104B2 (en) * 2001-10-17 2009-02-24 Kirin Beer Kabushiki Kaisha Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors
IL164209A0 (en) * 2002-05-31 2005-12-18 Eisai Co Ltd Pyrazole derivatives and pharmaceutical compositions containing the same
DE10342503A1 (de) * 2003-09-12 2005-04-14 Merck Patent Gmbh Benzyl-Benzimidazolylderivate
CA2568050A1 (en) 2004-05-26 2005-12-08 Pfizer, Inc. Indazole and indolone derivatives and their use as pharmaceuticals
WO2007058626A1 (en) 2005-11-16 2007-05-24 S*Bio Pte Ltd Indazole compounds
JP2009531274A (ja) * 2005-12-07 2009-09-03 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド キナーゼ阻害性ピロロピリジン化合物
WO2008074749A1 (en) 2006-12-20 2008-06-26 Nerviano Medical Sciences S.R.L. Indazole derivatives as kinase inhibitors for the treatment of cancer
US7737149B2 (en) * 2006-12-21 2010-06-15 Astrazeneca Ab N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
CL2008001633A1 (es) 2007-06-05 2008-12-12 Schering Corp Compuestos derivados de pirrolidin-3-carboxamida; composición farmacéutica; y uso comominhibidores de erk para el tratamiento del cancer.
DE102007028521A1 (de) 2007-06-21 2008-12-24 Merck Patent Gmbh Indazolamidderivate
EP2265270A1 (en) * 2008-02-04 2010-12-29 OSI Pharmaceuticals, Inc. 2-aminopyridine kinase inhibitors

Also Published As

Publication number Publication date
BRPI1013748A2 (pt) 2016-04-05
ME01462B (me) 2014-04-20
HRP20130323T1 (en) 2013-05-31
NZ595553A (en) 2013-05-31
PL2427449T3 (pl) 2013-08-30
TWI382982B (zh) 2013-01-21
CL2011002781A1 (es) 2012-05-25
KR101373910B1 (ko) 2014-03-12
AR078411A1 (es) 2011-11-09
PT2427449E (pt) 2013-05-06
MY160390A (en) 2017-03-15
UA104756C2 (uk) 2014-03-11
IL216004A0 (en) 2012-01-31
WO2010129509A1 (en) 2010-11-11
AU2010246114B2 (en) 2012-12-06
RS52795B (en) 2013-10-31
EA201171367A1 (ru) 2012-04-30
CN102421769A (zh) 2012-04-18
EA018149B1 (ru) 2013-05-30
JP2012526126A (ja) 2012-10-25
EP2427449B1 (en) 2013-04-03
CR20110580A (es) 2012-01-06
IL216004A (en) 2014-01-30
ECSP11011441A (es) 2011-12-30
CN102421769B (zh) 2014-04-02
CO6450624A2 (es) 2012-05-31
US8268869B2 (en) 2012-09-18
MA33244B1 (fr) 2012-05-02
US20100286209A1 (en) 2010-11-11
MX2011011342A (es) 2011-11-18
SG175909A1 (en) 2011-12-29
AU2010246114A1 (en) 2011-11-03
CA2760535C (en) 2014-01-14
HN2011002809A (es) 2013-07-22
PE20120812A1 (es) 2012-07-08
KR20120004511A (ko) 2012-01-12
CA2760535A1 (en) 2010-11-11
JP5555314B2 (ja) 2014-07-23
HK1163665A1 (en) 2012-09-14
JO2860B1 (en) 2015-03-15
PE20160124A1 (es) 2016-02-24
SI2427449T1 (sl) 2013-05-31
ES2408117T3 (es) 2013-06-18
EP2427449A1 (en) 2012-03-14
TW201105652A (en) 2011-02-16

Similar Documents

Publication Publication Date Title
CY2017026I1 (el) Τετρακυκλικη ενωση
SMT201600008B (it) Composti di piridazinone
BR112012006859A2 (pt) compostos
DK2427449T3 (da) Vinylindazolylforbindelser
BRPI1008774A2 (pt) espiroamida substituída
DK2414015T3 (da) Laryngoskopsystem
DE112010004215A5 (de) Hydrostataktor
DE112010002949A5 (de) Kupplungstastpunkte
BRPI1013614A2 (pt) compostos substituídos de espiro-amida
DK2411442T4 (da) Umættet polyesterresin
BRPI1005525A2 (pt) compostos de azaazuleno
BRPI1013868A2 (pt) composto diaciletilenodiamina
BRPI1008827A2 (pt) deisobutenizador
DK2430035T3 (da) Uracylspipooxetannukleosider
BRPI1014968A2 (pt) subalargador
DE112010002728A5 (de) Turboinhalator
UY33156A (es) Nuevos compuestos tienopirrol
DE112009005323A5 (de) Hebelarmprüfmaschine
DE112010004249A5 (de) Spindelaktor
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BRPI1008070A2 (pt) tricianoboratos
BR112012004964A2 (pt) girocóptero
DK2483126T3 (da) Skinnekøretøj
DE112010004865T8 (de) Lamellennassreibkupplung
DK2506968T3 (da) Faujasit-zeolit